泰达生物2026年9月股份变动月报:股本维持不变

公告速递
Oct 06

天津泰达生物医学工程股份有限公司(股票代码:08189)于2026年10月6日发布截至2026年9月30日止的股份变动月报表。报告期内,公司法定/注册股本总额人民币213,390,000元,与上月保持一致。公司本月未新增发行股份、未进行股份购回或注销,股份总数保持稳定。

根据公告,报告期内公司普通股共分为H股和内资股两类。H股已发行股份数量为1,436,400,000股,每股面值人民币0.1元,内资股已发行股份数量为697,500,000股,每股面值人民币0.1元,合计注册股本为人民币213,390,000元。

公告未显示当月存在股份期权或其他股权激励的授出、行使或失效情况,也无其他股份发行协议或安排的更新。同时,公司确认已符合及遵守香港联交所《上市规则》及其他相关法律法规的规定。

上述月报由公司董事会授权并由董事兼秘书孙莉签署。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10